Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib
Condition(s):Clear Cell Metastatic Renal Cell CarcinomaLast Updated:March 23, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Clear Cell Metastatic Renal Cell CarcinomaLast Updated:March 23, 2021Completed
Condition(s):Brain MetastasesLast Updated:January 31, 2024Active, not recruiting
Condition(s):Prostatic NeoplasmsLast Updated:March 8, 2022Unknown status
Condition(s):Radiotherapy; Spine Metastases; RadiosurgeryLast Updated:July 19, 2019Unknown status
Condition(s):Locally Advanced Pancreatic CancerLast Updated:April 20, 2022Completed
Condition(s):Malignant GliomaLast Updated:January 5, 2024Active, not recruiting
Condition(s):Pancreatic NeoplasmsLast Updated:July 29, 2020Completed
Condition(s):Lung NeoplasmLast Updated:November 2, 2023Recruiting
Condition(s):Brain Metastasis; OligoprogressionLast Updated:November 30, 2023Active, not recruiting
Condition(s):Bone Metastases; Radiotherapy Side EffectLast Updated:August 21, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.